T. Rowe Price cuts Transcat stake to 0.0%
T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G to report its holdings in Transcat Inc. (TRNS) common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G to report its holdings in Transcat Inc. (TRNS) common stock. The firm reports beneficial ownership of 59 shares, representing 0.0% of the class as of the reported date.
The filer states it has sole voting and dispositive power over these 59 shares and no shared power. It also indicates that it now owns 5 percent or less of Transcat’s common stock and that the position is held in the ordinary course of business, not to influence control of the company, while expressly denying beneficial ownership of the securities referenced.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did T. Rowe Price report in its amended Schedule 13G for TRNS?
What percentage of Transcat (TRNS) does T. Rowe Price’s position represent?
Is T. Rowe Price seeking to influence control of Transcat (TRNS)?
When did the Transcat (TRNS) ownership level triggering this filing occur?
AI-generated analysis. How Rhea-AI works. Not financial advice.